Specialty PACS Market (By Type, By Component, By Deployment Model, By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030

The specialty PACS market size was valued at USD 3.4 billion in 2021 and it is expected to surpass around USD 5.8 billion by 2030, registering growth at a CAGR of 6.11% during the forecast period 2022 to 2030.

Specialty PACS Market Size 2021 to 2030

PACS (picture archiving and communication system) is a medical imaging technology used primarily in healthcare organizations to securely store and digitally transmit electronic images and clinically-relevant reports. The use of PACS eliminates the need to manually file, store, retrieve, and send sensitive information, films, and reports. In addition, medical documentation and images can be securely housed in off-site servers and safely accessed essentially from anywhere in the world using PACS software, workstations, and mobile devices. Medical imaging storage technologies such as PACS are increasingly important as the volume of digital medical images grow throughout the healthcare industry and data analytics of those images become more prevalent. PACS has four major parts, namely, hardware imaging machines; a secure network for the distribution and exchange of patient images; a workstation or mobile device for viewing, processing, and interpreting images; and electronic archives for storing and retrieving images and related documentation and reports. PACS has various uses that include replacement for need of hard-copy films and management of physical archives. It allows remote access, enabling clinicians in different physical locations to review same data simultaneously.

Increase in geriatric population and growing medical imaging volumes are the key factors that fuel growth of the specialty PACS market. Moreover, rise in prevalence of chronic diseases, increase in investments in medical imaging, rise in use of imaging equipment, increase in adoption of medical imaging health care IT solutions, rise in advancements in specialty PACS, growth in government initiatives to propel adoption of healthcare IT solution, and rise in awareness regarding early disease diagnosis are other factors that contribute toward growth of the market. However, unawareness among people regarding the technology, increase in cost of treatment, slow development in specialty PACS, and less government initiatives are expected to hinder growth of the market. Furthermore, rise in ambulatory centers, increase in advancements in R&D, reduced cost of product and treatment, rise in hospital facilities, and advancements in imaging solution provides lucrative opportunities for the market growth.

The growing geriatric population and consequent increase in the incidence of various diseases, benefits associated with specialty PACS, government efforts boost the acceptance of healthcare IT solutions, rising investments in medical imaging, increased adoption of medical imaging IT solutions, and expanding use of imaging equipment are some of the key drivers for the market growth. However, budgeting restrictions are expected to restrain the market growth.

Report Scope Details
Market Size by 2030 USD 5.8 Billion
CAGR form 2022 to 2030 6.11%
Largest Market North America
Fastest Growing Market Asia Pacific
Forecast Period 2022 to 2030

 

By Type

Based on type, the market is categorized into radiology PACS, ophthalmology PACS, endoscopy PACS, oncology PACS, orthopaedics PACS, women's health PACS, pathology PACS, dermatology PACS, neurology PACS, and others. In 2021, the ophthalmology PACS segment accounted for the highest revenue share due to the increase in the number of eye procedures, the rising incidence of eye problems and illnesses, and technical developments in ophthalmology equipment.

By Component

On the basis of component, the market is segregated into software, services, and hardware. In 2021, the software segment accounted for the highest revenue share owing to the ever rising volume of healthcare imaging.

By Deployment Model

Based on component, the market is bifurcated into cloud-based and on-premise. In 2021, the on-premise segment accounted for the highest revenue share due to the fact that on-premise solutions are more easily customised than web/cloud-based specialist PACS.

By End user

On the basis of end user, the market is categorized into ambulatory surgery centres, diagnostic imaging centres, hospitals, and others. In 2021, the hospitals segment accounted for the highest revenue share owing to the growing number of patients, fast expansion of EMR adoption, technical developments in imaging techniques, increasing understanding of the advantages of early illness detection, and growing patient data digitalization,

Regional Markets

In 2021, North America region accounted for the highest revenue in the laboratory information systems market and is expected to maintain its dominance during the forecast period. This is attributed to large economies of the United States and Canada have permitted large investments in new technologies, growth in biobanks, simple availability of LIMS products and services, and severe regulatory requirements across industries. Furthermore, rising investment in pharmaceutical research and development is hastening regional market expansion.

KEY MARKET PLAYERS

  • Canon Inc. (Canon Medical System Corporation)
  • INC Escalon Medical Corp.
  • EyePACS, LLC
  • IBM Corporation
  • INFINITT Healthcare Co. Ltd.
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Novarad
  • Onex Corporation (Carestream Health)
  • Siemens AG

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2022 to 2030, which assists to identify the prevailing market opportunities.
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the specialty PACS market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves

 Segmentation: Specialty PACS Market

By Type

  • Radiology PACS
  • Ophthalmology PACS
  • Endoscopy PACS
  • Women's Health PACS
  • Oncology PACS
  • Orthopaedics PACS
  • Pathology PACS
  • Dermatology PACS
  • Neurology PACS
  • Others

By Component

  • Software
  • Services
  • Hardware

By Deployment Model

  • Cloud-based
  • On-premise

By End user

  • Ambulatory Surgery Centres
  • Diagnostic Imaging Centres
  • Hospitals
  • Others

By Region

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA


1. Research Methodology

1.1.Study Objectives
1.2.Study Scope
1.3.Research Assumptions
1.4.Research Framework
1.4.1.Research Models
1.4.1.1.Bottom-up Approach
1.4.1.2.Top-down Approach
1.4.1.3.Data Triangulation
1.4.2.Data Procurement
1.4.2.1.Internal Database
1.4.2.2.Secondary Research
1.4.2.3.Purchased Database
1.4.2.4.Primary Research
1.4.3.Data Analysis
1.4.3.1.Data Validation
1.4.3.2.Market Size Estimation
1.4.3.3.Market Forecast Model
1.4.4.Quality Assessment

2. Introduction: Specialty PACS

3. Executive Summary

3.1.Global Market Scenario
3.2.Segment Market Scenario
3.3.Geographic Market Scenario
3.4.COVID-19 Impact
3.5.Competitive Landscape

4. Market Dynamics

4.1. Market Drivers
4.1.1.Driver 1
4.1.2.Driver 2
4.1.3.Driver 3
4.1.4.Driver 4
4.1.5.Driver 5
4.2.Market Restraint
4.2.1.Restraint 1
4.2.2.Restraint 2
4.2.3.Restraint 3
4.2.4.Restraint 4
4.3.Market Opportunities
4.3.1.Opportunity 1
4.3.2.Opportunity 2
4.3.3.Opportunity 3
4.3.4.Opportunity 4
4.4.Market Trends
4.4.1.Trend 1
4.4.2.Trend 2
4.4.3.Trend 3
4.4.4.Trend 4
4.5.Market Challenges
4.5.1.Challenge 1
4.5.2.Challenge 2
4.5.3.Challenge 3
4.5.4.Challenge 4

5. Market Environment Analysis

5.1.Porter’s 5 Forces Analysis
5.2.PESTEL Analysis
5.3.Value Chain Analysis
5.4.SWOT Analysis
5.5.Benchmark

6. COVID-19 Impact Analysis: Specialty PACS Market

6.1.COVID-19: Overview
6.2.COVID-19 Impact on the Global Market
6.3.COVID-19 Impact on the Regional Markets

7. Market Analysis by Type

7.1.Radiology PACS
7.1.1.Radiology PACS Market Forecast, 2021-2029 (USD Million)
7.2.Ophthalmology PACS7
7.2.1.Ophthalmology PACS Market Forecast, 2021-2029 (USD Million)
7.3.Endoscopy PACS
7.3.1.Endoscopy PACS Market Forecast, 2021-2029 (USD Million)
7.4.Women's Health PACS
7.4.1.Women's Health PACS Market Forecast, 2021-2029 (USD Million)
7.5.Oncology PACS
7.5.1.Oncology PACS Market Forecast, 2021-2029 (USD Million)
7.6.Orthopaedics PACS
7.6.1.Orthopaedics PACS Market Forecast, 2021-2029 (USD Million)
7.7.Pathology PACS
7.7.1.Pathology PACS Market Forecast, 2021-2029 (USD Million)
7..8. Dermatology PACS
7.7.2.Dermatology PACS Market Forecast, 2021-2029 (USD Million)
7.8.Neurology PACS
7.8.1.Neurology PACS Market Forecast, 2021-2029 (USD Million)
7.9.Others
7.9.1.Others Market Forecast, 2021-2029 (USD Million)

8. Market Analysis by Component

8.1.Software
8.1.1.Software Market Forecast, 2021-2029 (USD Million)
8.2.Services
8.2.1.Services Market Forecast, 2021-2029 (USD Million)
8.3.Hardware
8.3.1.Hardware Market Forecast, 2021-2029 (USD Million)

9. Market Analysis by Deployment Model

9.1.Cloud-based
9.1.1.Cloud-based Market Forecast, 2021-2029 (USD Million)
9.2.On-premise
9.2.1.On-premise Market Forecast, 2021-2029 (USD Million)

9. Market Analysis by End user

9.1.Ambulatory Surgery Centres
9.1.1.Ambulatory Surgery Centres Market Forecast, 2021-2029 (USD Million)
9.2.Diagnostic Imaging Centres
9.2.1.Diagnostic Imaging Centres Market Forecast, 2021-2029 (USD Million)
9.1.Hospitals
9.1.1.Hospitals Market Forecast, 2021-2029 (USD Million)
9.2.Others
9.2.1.Others Market Forecast, 2021-2029 (USD Million)

10. Regional Market Analysis

10.1.Regional Market Trends
10.2.Regional Market: Comparative Analysis

11. North America Specialty PACS Market

11.1.North America Specialty PACS Market
11.1.1.North America Market Size and Forecast, 2021-2029 (USD Million)
11.1.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
11.1.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
11.1.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
11.1.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
11.2.U.S. Specialty PACS Market
11.2.1.U.S. Market Size and Forecast, 2021-2029 (USD Million)
11.2.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
11.2.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
11.2.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
11.2.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
11.3.Canada Specialty PACS Market
11.3.1.Canada Market Size and Forecast, 2021-2029 (USD Million)
11.3.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
11.3.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
11.3.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
11.3.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)

12. Europe Specialty PACS Market

12.1.Europe Specialty PACS Market
12.1.1.Europe Market Size and Forecast, 2021-2029 (USD Million)
12.1.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
12.1.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
12.1.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
12.1.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
12.2.Germany Specialty PACS Market
12.2.1.Germany Market Size and Forecast, 2021-2029 (USD Million)
12.2.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
12.2.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
12.2.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
12.2.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
12.3.UK Specialty PACS Market
12.3.1.UK Market Size and Forecast, 2021-2029 (USD Million)
12.3.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
12.3.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
12.3.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
12.3.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
12.4.France Specialty PACS Market
12.4.1.France Market Size and Forecast, 2021-2029 (USD Million)
12.4.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
12.4.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
12.4.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
12.4.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
12.5.Spain Specialty PACS Market
12.5.1.Spain Market Size and Forecast, 2021-2029 (USD Million)
12.5.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
12.5.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
12.5.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
12.5.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
12.6.Italy Specialty PACS Market
12.6.1.Italy Market Size and Forecast, 2021-2029 (USD Million)
12.6.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
12.6.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
12.6.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
12.6.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
12.7.Rest of EuropeSpecialty PACS Market
12.7.1.Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
12.7.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
12.7.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
12.7.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
12.7.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)

13. Asia PacificSpecialty PACS Market

13.1.Asia PacificSpecialty PACS Market
13.1.1.Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
13.1.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
13.1.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
13.1.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
13.1.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
13.2.Japan Specialty PACS Market
13.2.1.Japan Market Size and Forecast, 2021-2029 (USD Million)
13.2.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
13.2.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
13.2.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
13.2.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
13.3.China Specialty PACS Market
13.3.1.China Market Size and Forecast, 2021-2029 (USD Million)
13.3.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
13.3.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
13.3.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
13.3.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
13.4.India Specialty PACS Market
13.4.1.India Market Size and Forecast, 2021-2029 (USD Million)
13.4.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
13.4.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
13.4.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
13.4.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
13.5.South Korea Specialty PACS Market
13.5.1.South Korea Market Size and Forecast, 2021-2029 (USD Million)
13.5.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
13.5.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
13.5.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
13.5.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
13.6.Australia Specialty PACS Market
13.6.1.Australia Market Size and Forecast, 2021-2029 (USD Million)
13.6.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
13.6.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
13.6.1.3.Market Size and Forecast by Deployment Model 2021-2029 (USD Million)
13.6.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
13.7.Rest of Asia Pacific Specialty PACS Market
13.7.1.Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
13.7.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
13.7.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
13.7.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
13.7.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)

14. Latin America Specialty PACS Market

14.1.Latin America Specialty PACS Market
14.1.1.Latin America Market Size and Forecast, 2021-2029 (USD Million)
14.1.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
14.1.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
14.1.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
14.1.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
14.2.BrazilSpecialty PACS Market
14.2.1.Brazil Market Size and Forecast, 2021-2029 (USD Million)
14.2.1.1.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
14.2.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
14.2.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
14.2.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
14.3.MexicoSpecialty PACS Market
14.3.1.Mexico Market Size and Forecast, 2021-2029 (USD Million)
14.3.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
14.3.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
14.3.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
14.3.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
14.4.Argentina Specialty PACS Market
14.4.1.Argentina Market Size and Forecast, 2021-2029 (USD Million)
14.4.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
14.4.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
14.4.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
14.4.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
14.5.Rest of Latin America Specialty PACS Market
14.5.1.Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
14.5.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
14.5.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
14.5.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
14.5.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)

15. MEASpecialty PACS Market

15.1.MEA Specialty PACS Market
15.1.1.MEA Market Size and Forecast, 2021-2029 (USD Million)
15.1.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
15.1.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
15.1.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
15.1.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
15.2.GCC Specialty PACS Market
15.2.1.GCC Market Size and Forecast, 2021-2029 (USD Million)
15.2.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
15.2.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
15.2.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
15.2.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
15.3.South Africa Specialty PACS Market
15.3.1.South Africa Market Size and Forecast, 2021-2029 (USD Million)
15.3.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
15.3.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
15.3.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
15.3.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)
15.4.Rest of MEA Specialty PACS Market
15.4.1.Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
15.4.1.1.Market Size and Forecast by Type, 2021-2029 (USD Million)
15.4.1.2.Market Size and Forecast by Component, 2021-2029 (USD Million)
15.4.1.3.Market Size and Forecast by Deployment Model, 2021-2029 (USD Million)
15.4.1.4.Market Size and Forecast by End user, 2021-2029 (USD Million)

16. Competitor Analysis

16.1.Market Share Analysis, 2021 & 2029
16.2.Competitive Mapping
16.3.Key Players Market Place Analysis
16.4.Major Recent Developments

17. Company Profiles

17.1.IBM Corporation (Merge Healthcare Incorporated) (US)
17.1.1.Company Snapshot
17.1.2.Company Overview
17.1.3.Financials
17.1.4.Component Benchmarking
17.1.5.Recent Developments
17.2.McKesson Corporation (US)
17.2.1.Company Snapshot
17.2.2.Company Overview
17.2.3.Financials
17.2.4.Component Benchmarking
17.2.5.Recent Developments
17.3.Agfa Healthcare (Belgium)
17.3.1.Company Snapshot
17.3.2.Company Overview
17.3.3.Financials
17.3.4.Component Benchmarking
17.3.5.Recent Developments
17.4.Carestream Health (a part of Onex Corporation) (Canada)
17.4.1.Company Snapshot
17.4.2.Company Overview
17.4.3.Financials
17.4.4.Component Benchmarking
17.4.5.Recent Developments
17.5.Philips Healthcare (Netherlands)
17.5.1.Company Snapshot
17.5.2.Company Overview
17.5.3.Financials
17.5.4.Component Benchmarking
17.5.5.Recent Developments
17.6.Sectra AB (Sweden)
17.6.1.Company Snapshot
17.6.2.Company Overview
17.6.3.Financials
17.6.4.Component Benchmarking
17.6.5.Recent Developments
17.7.Siemens Healthineers (Germany)
17.7.1.Company Snapshot
17.7.2.Company Overview
17.7.3.Financials
17.7.4.Component Benchmarking
17.7.5.Recent Developments
17.8.Novarad (US)
17.8.1.Company Snapshot
17.8.2.Company Overview
17.8.3.Financials
17.8.4.Component Benchmarking
17.8.5.Recent Developments
17.9.INFINITT North America (US)
17.9.1.Company Snapshot
17.9.2.Company Overview
17.9.3.Financials
17.9.4.Component Benchmarking
17.9.5.Recent Developments
17.10.Intelerad Medical Systems (Canada)
17.10.1.Company Snapshot
17.10.2.Company Overview
17.10.3.Financials
17.10.4.Component Benchmarking
17.10.5.Recent Developments
17.11. Topcon Corporation (Japan)
17.11.1.Company Snapshot
17.11.2.Company Overview
17.11.3.Financials
17.11.4.Component Benchmarking
17.11.5.Recent Developments
17.12.Sonomed Escalon (US)
17.12.1.Company Snapshot
17.12.2.Company Overview
17.12.3.Financials
17.12.4.Component Benchmarking
17.12.5.Recent Developments
17.13.Canon USA, Inc. (US)
17.13.1.Company Snapshot
17.13.2.Company Overview
17.13.3.Financials
17.13.4.Component Benchmarking
17.13.5.Recent Developments
17.14.Visbion (UK)
17.14.1.Company Snapshot
17.14.2.Company Overview
17.14.3.Financials
17.14.4.Component Benchmarking
17.14.5.Recent Developments
17.15. EyePACS, LLC (US)
17.15.1.Company Snapshot
17.15.2.Company Overview
17.15.3.Financials
17.15.4.Component Benchmarking
17.15.5.Recent Developments
17.16.Others Prominent Players

18. Conclusion & Recommendations

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask to Expert